Data entered in the Eurocrine database may be used for clinical research purposes, within the aim and scope of the registry after obtaining approval from the appropriate ethical review board, and subject to this approval.

Additionally, for prospective observational studies and randomized controlled trials (RCTs) patients should receive written and oral information about the study and provide explicit consent, written or electronically.